Bayer Intellectual Property GMBH et al v. ScieGen Pharmaceuticals, Inc. > Summary
Court Case Number 1:23-cv-00335
Filing Date Mar 24, 2023
Termination Date May 3, 2023
Court Delaware District Court
Status Dismissed - Other
JudgesRichard G. Andrews
Plaintiff
4Defendant
Plaintiff Attorneys
12JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
Defendant Attorneys
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10828310 | Reducing the risk of cardiovascular events | Nov 10, 2020 |
| 09539218 | Prevention and treatment of thromboembolic disorders | Jan 10, 2017 |
